A fully virtual accelerator with curriculum, mentorship, and resources calibrated to your company’s stage, your market, and your next move.
Applications close December 1
Incubators and accelerators both support early-stage companies, and the two words often get used interchangeably. They are not the same thing. Here is what each one does, and where MedTech Innovator fits.
The program delivers six types of support to every founder, regardless of where their company is.
The Curriculum
:format(webp))
The Research Library
:format(webp))
Your Advisory Committee
:format(webp))
The Thesis
:format(webp))
The Showcase
:format(webp))
The Cohort
:format(webp))
Neal Piper
MedTech Innovator has been transformative for Luminoah. At the MTI reception with MedTech World, we met an investor who committed $300K to our Series A2, bringing us closer to completing our $5M round and positioning us for our upcoming Series B.
None of this would have been possible without the visibility, connections, and support we’ve gained through MTI.
Fiona Simpson
MTI has opened doors I did not even know existed to be opened.
Love hearing this, Fiona. Thank you!
How MTI helped Tempo Therapeutics
Westbrook Weaver
The way that MedTech Innovator has helped our company is really in two key ways. One is through the value story and creating the sort of value worksheet that we’ve worked through to understand how we communicate, quantify, measure, and design the value of our product.
Westbrook
Peter Devlin
I think for me it’s a really amazing experience to be able to have access for me and my team to an amazing group of resources and talented people that can really help elevate our knowledge and understanding about how to successfully build an early stage medtech company.
A note of thanks from RenewRx
Kelly Carter
Hi everyone,
MTI has been a game changer for us. The pitch event gave us immediate, actionable feedback, and the support beyond the curriculum is what truly sets MTI apart: branding, visibility, access to decision makers we wouldn’t have had otherwise.
The team is incredibly thoughtful about uplifting every company while building a world class brand of their own.
Kelly, COO
Emily Mirro
MTI has been great at helping connect us with not only investors, but other founders that are very mission aligned like we are.
Peter Boyd
The ability to articulate our value proposition in a clear and compelling manner has been really helpful for us.
So glad it’s paying off. Thanks, Peter!
Kelly Carter
MTI has been a game changer for us. The pitch event gave us immediate, actionable feedback. What sets MTI apart is the support beyond the curriculum: branding, visibility, access to decision makers we wouldn’t have had otherwise.
This just made our week. Thank you, Kelly.
Tim Gleeson
The ability to get information, get access to investors, get access to strategics, get access to press, learn along the way… at every turn has been sort of like exceeded expectations.
A note from EpiWatch
Teresa Prego
So you would think when you bring all of these brilliant people together with these great ideas that it might get into a competitive mess. It’s the complete opposite. It’s been this great community of trying to figure out how can everyone be successful, how can we move these ideas forward.
Teresa
Andy Seykora
There’s a lot of value and connection that will save way more time than you put into this and connect you in ways that are just going to save time, I think, in raising money.
A note from Sonorous Neurovascular
Joel Harris
We’ve watched all of the webinars that have been going on and participated both myself and our CEO has been very active in it I think it’s really helped us flesh out and done a better job on really providing our value to our current investors.
Joel
Andrew Ortega-Verdaguer
I see the MTI like a big community of friends that we all are looking for doing good for the health of patients…
A note from ARTINESS
Filippo Piatti
MTI provided a lot of network, expertise, and guidance to move the steps toward the U.S. environment… And of course, opening a lot to a network of investors and venture capitals that can provide enough resources to tackle the market.
Filippo
The founders who get the most from MTI come in knowing roughly where they’re going and are hungry for the network, mentorship, and intelligence to close the gap faster. They’re building a medical device, diagnostic, or digital health solution with a clear clinical use case. They have early data, a regulatory strategy taking shape, and real commercial questions in front of them. They’re working through what medtech specifically makes hard: the long path to clearance, the complexity of hospital procurement, the challenge of finding investors who understand the space.
They’re not looking for a class to sit through. They want five months of the right people in the room.
If this is you…
Apply nowAreas of interest
:format(webp))
Radar is MTI’s multi-stage evaluation process, running from October through May. It’s competitive by design, and every applicant receives meaningful feedback at each stage, making it worth applying regardless of where your company is.
Applications open in October and close in December. Every submission is reviewed by MTI’s network of expert advisors, clinicians, and industry partners. Companies that advance are invited to pitch, either at a virtual Radar Pitch Event or in person at the annual Radar Forum, where they present to industry leaders and receive live evaluation and direct diligence feedback. A strategic selection committee then reviews all Radar companies and makes final cohort selections in May.
Every cohort starts the same way and ends on the same stage. What happens in between is shaped entirely by where your company is.
Apply
Applications are open now and close December 1.
Pitch
Applications are reviewed by MTI’s extensive ecosystem of experts. Companies are invited to pitch at our annual Radar Forum, held April 5–9, 2027 in Washington, DC, or virtually. Cohort selections are announced in May, following the full Radar evaluation process.
Program Kickoff
Three days of intensive programming, mentor introductions, working sessions with partners, and the first chance to meet the fellow founders who will make the journey together.
Accelerator in Action
Weekly webinars, SPARK workshops, and office hours run throughout. Specialty track programming runs in parallel for companies in focused tracks. The Value Program builds toward the finals competition.
Culmination
Every cohort company is featured at the MedTech Innovator Showcase, with stage time in front of investors, strategics, and industry leaders. For early-stage companies, Finals competitors pitch live for the $350,000 grand prize. Mid-stage companies compete at MedTech Strategist. A chance for the whole cohort to come together and celebrate how far they’ve come.
TIME
No. 1 Health and Life Sciences Accelerator in the United States. Ranked 31st overall out of 80 programs nationally.
Strategic partners
MTI’s partners include the strategics, foundations, and clinical organizations shaping the future of the industry.
:format(webp))
It really is a win-win situation; we get the benefits of early access to start-ups from a deal flow perspective, while they get the opportunity to tap into our expertise and guidance.
Jennifer Kozak
Vice President Business Development, Johnson & Johnson MedTech
:format(webp)){kind=logo}
:format(webp))
When we engage with a company here, we’re not just offering them money… We’re offering them the resources of the American Heart Association… Our goal, really, is to get solutions for patients into the hands of doctors and hospitals in order to improve outcomes.
Mitchell Elkind
Chief Clinical Science Officer, American Heart Association
:format(webp)){kind=logo}
:format(webp))
The quality of the companies that are attracted to MedTech Innovator are outstanding. But for me, it’s a lot more than that. It’s the community that it forms… It’s an amazing network to have, but also the community with the different startup companies.
Virginia Giddings
Edwards Lifesciences
:format(webp)){kind=logo}
:format(webp))
:format(webp))